About R S M Pharma Private Limited
Data last updated:
R S M Pharma Private Limited is a private limited company based in Bangalore, Karnataka, India, a subsidiary of Entero Healthcare Solutions Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 March 1989 and has been in existence for over 37 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U85110KA1989PTC009974. Its GSTIN is 29AAACR6558F1Z4 (Karnataka).
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.5 Cr. It is led by directors including Sreekantiah Bangalore Deepak and Sumitra Sachin Jadhav.
Its last annual general meeting (AGM) was held on 16 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹363.29 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹4.16 Cr (net margin 1.1%) and EBITDA of ₹11.21 Cr (EBITDA margin 3.1%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 20% over five years.
The company has about 255 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: RSM Pharma. As per MCA filings, the company has open charges of ₹60 Cr and satisfied charges of ₹67.88 Cr on record. Court records list 71 cases involving the company, including 68 filed by the company and 3 filed against it; 12 cases are pending. The company has 7 deals on record (4 secondary share transfers, 3 funding rounds), with disclosed funding of ₹1.05 Cr; the latest was in August 2019. Its 7 peer companies in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 4 larger and 3 smaller; the largest is Plus Distribution Private Limited with revenue of ₹386.16 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rsmpharma.net.
Company details
CIN history
R S M Pharma has one previous CIN (Corporate Identification Number): U51397KA1989PTC009974. The current CIN is U85110KA1989PTC009974, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85110KA1989PTC009974 | Current |
| U51397KA1989PTC009974 | Previous |
Contact details
R S M Pharma Private Limited's registered office is in Bangalore, Karnataka. Its website is rsmpharma.net. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address1st Floor No.260/1/36/2C Pattangere Global Village Road Near Metro Cash & C, Arry, Bangalore, Karnataka, India – 560059
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of R S M Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
R S M Pharma operates one associated brand: RSM Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Generics and biosimilar drugs are manufactured in Bengaluru, India. | rsmpharma.in |
Business activity
The main business activity of R S M Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of R S M Pharma Private Limited, buy the company report.
Financials of R S M Pharma Private Limited
FY 2025 filings availableR S M Pharma Private Limited reported revenue of ₹363.29 Cr (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 6% growth in the latest year. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.21 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.16 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.1% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of R S M Pharma Private Limited, buy the company report.
Board of directors of R S M Pharma Private Limited
R S M Pharma has 4 current directors and 15 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sumitra Sachin Jadhav | Additional Director | 12 Jan 2026 | 0 Years 9 Months | Current |
| Abhinav Choudhary Also directs: Sai Pharma Distributors Private Limited, City Pharma Distributors Private Limited, Srinivasa Lifecare Private Limited and 5 more | Additional Director | 11 Nov 2025 | 0 Years 11 Months | Current |
| Venkatasubramanian Kishowre Also directs: Saarthak Desk Private Limited, Nirvahi India Private Limited | Additional Director | 27 Nov 2025 | 0 Years 11 Months | Current |
| Sreekantiah Bangalore Deepak Also directs: Avenues Pharma Distributors Private Limited | Director | 11 Feb 2025 | 1 Years 8 Months | Current |
Peer comparison
R S M Pharma Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Plus Distribution Private Limited | ₹386.16 Cr (FY 2024) | 91.0% | Gurgaon, Haryana, India | |||
| Albino Lifesciences Private Limited | ₹385.47 Cr (FY 2025) | 13.0% | New Delhi, Delhi, India | |||
| Purani Hospital Supplies Private Limited | ₹379 Cr (FY 2025) | 9.0% | Coimbatore, Tamil Nadu, India | |||
| Martin and Harris Enterprises Private Limited | ₹373.99 Cr (FY 2025) | 675.0% | Mumbai, Maharashtra, India | |||
| R S M Pharma Private Limitedthis company | ₹363.29 Cr (FY 2025) | ₹4.16 Cr | 1.1% | 6.0% | 255 | Bangalore, Karnataka, India |
| A M Pharmaceuticals (India) Private Limited | ₹359.11 Cr (FY 2025) | 6.0% | Thrissur, Kerala, India | |||
| Pangea Enterprises Private Limited | ₹353.08 Cr (FY 2025) | -3.0% | New Delhi, Delhi, India | |||
| Sai Sridhar Pharma Private Limited | ₹349.28 Cr (FY 2025) | -21.0% | Hyderabad, Telangana, India |
To see the full peer comparison of R S M Pharma Private Limited, buy the company report.
Auditor
R S M Pharma Private Limited is audited by M S K A & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M S K A & ASSOCIATES | FY 2023 | 105047W |
Shareholding
The shareholding of R S M Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of R S M Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Feb 2022 | 100546161 | Others | ₹60 Cr | Open | |
| 31 May 2019 | 100272761 | Others | ₹15 Cr | Satisfied | |
| 31 Aug 2018 | 100200206 | Others | ₹10 Cr | Satisfied | |
| 22 Jul 2013 | 10438716 | The Hongkong and Shanghai Banking Corporation Ltd | ₹20 Cr | Satisfied | |
| 19 May 2010 | 10220581 | Standard Chartered Bank | ₹15 Cr | Satisfied |
To see the full charge records of R S M Pharma Private Limited, buy the company report.
Total charge records: 9 View all charges
Deals & funding
R S M Pharma Private Limited has 7 deals on record (4 secondary share transfers, 3 funding rounds), with disclosed funding of ₹1.05 Cr; the latest was in August 2019.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2019 | Secondary share transfer | Undisclosed | Buyer: Entero Healthcare Solutions Limited Seller: Sitaram Sarda HUF, Champalal Siremalji HUF, 2 individuals |
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Unnati Polymers Private Limited |
| Mar 2009 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2008 | Funding round | ₹10 Lakh | Investors: Unnati Polymers Private Limited |
| Mar 2008 | Secondary share transfer | Undisclosed | Buyer: Unnati Polymers Private Limited , 3 individuals Seller: Vinod Nahar (HUF), Vijay Nahar (HUF), 2 individuals |
To see the full deal history of R S M Pharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
R S M Pharma Private Limited has 71 court cases on record: 68 filed by R S M Pharma, 3 filed against it. 12 cases are pending and 59 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 70 | 2 | 12 |
| High courts | 1 | 1 | 0 |
Cases on record (5 of 71)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Execution petition | Filed by the company against an individual | Pending |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed by the company against an individual | Pending |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed by the company against an individual | Pending |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed by the company against an individual | Pending |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed by the company against an individual | Pending |
To see the full case history of R S M Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for R S M Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
R S M Pharma Private Limited has a workforce of 255 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
GST
R S M Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAACR6558F1Z4 | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of R S M Pharma Private Limited, buy the company report.
Recent activity
R S M Pharma Private Limited has 34 board changes on record since 2001: 19 appointments and 15 cessations. The latest: Sumitra Sachin Jadhav was appointed as Additional Director on 12 Jan 2026.
46 earlier events are in the company report.
Frequently asked questions
R S M Pharma is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 March 1989 (37+ years old) and is registered under CIN U85110KA1989PTC009974.
R S M Pharma has 4 current directors:
- Sumitra Sachin Jadhav - Additional Director
- Abhinav Choudhary - Additional Director
- Venkatasubramanian Kishowre - Additional Director
- Sreekantiah Bangalore Deepak - Director
The latest financial statements of R S M Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 16 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of R S M Pharma is 29AAACR6558F1Z4, registered in Karnataka.
The CIN (Corporate Identification Number) of R S M Pharma is U85110KA1989PTC009974. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
R S M Pharma has 71 court cases on record: 68 filed by the company and 3 filed against it. 12 are pending. Most are in the district courts.
R S M Pharma was incorporated on 30 March 1989, making it 37+ years old. It is registered with the Registrar of Companies, Bangalore.
R S M Pharma has 7 deals on record (4 secondary share transfers, 3 funding rounds), with disclosed funding of ₹1.05 Cr; the latest was in August 2019.
The peers of R S M Pharma by revenue are Plus Distribution Private Limited, Albino Lifesciences Private Limited, Purani Hospital Supplies Private Limited, Martin and Harris Enterprises Private Limited, A M Pharmaceuticals (India) Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Sumitra Sachin Jadhav was appointed as Additional Director on 12 Jan 2026. Prabhat Agrawal ceased to be Director on 05 Dec 2025. Sanu Vishal Kapoor ceased to be Director on 27 Nov 2025. R S M Pharma has 34 board changes on record in total.
R S M Pharma can be reached through the website rsmpharma.net. Its registered office is in Bangalore, Karnataka, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
